Monika Kasprzycka
Monika Kasprzycka
Oslo University Hospital, Rikshospitalet
Geverifieerd e-mailadres voor rr-research.no
Titel
Geciteerd door
Geciteerd door
Jaar
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
J Sponheim, J Pollheimer, T Olsen, J Balogh, C Hammarström, T Loos, ...
The American journal of pathology 177 (6), 2804-2815, 2010
1732010
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
M Kasprzycka, M Marzec, X Liu, Q Zhang, MA Wasik
Proceedings of the National Academy of Sciences 103 (26), 9964-9969, 2006
1422006
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity
M Marzec, M Kasprzycka, R Lai, AB Gladden, P Wlodarski, E Tomczak, ...
Blood 108 (5), 1744-1750, 2006
1392006
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway
M Marzec, M Kasprzycka, X Liu, M El-Salem, K Halasa, PN Raghunath, ...
Oncogene 26 (38), 5606-5614, 2007
1132007
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3
M Marzec, M Kasprzycka, A Ptasznik, P Wlodarski, Q Zhang, N Odum, ...
Laboratory investigation 85 (12), 1544-1554, 2005
992005
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells
M Marzec, K Halasa, M Kasprzycka, M Wysocka, X Liu, JW Tobias, ...
Cancer research 68 (4), 1083-1091, 2008
842008
Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf
M Marzec, M Kasprzycka, X Liu, PN Raghunath, P Wlodarski, MA Wasik
Oncogene 26 (6), 813-821, 2007
842007
Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal …
P Wlodarski, M Kasprzycka, X Liu, M Marzec, ES Robertson, A Slupianek, ...
Cancer research 65 (17), 7800-7808, 2005
812005
The alarmin IL-33 is a notch target in quiescent endothelial cells
E Sundlisæter, RJ Edelmann, J Hol, J Sponheim, AM Küchler, M Weiss, ...
The American journal of pathology 181 (3), 1099-1111, 2012
602012
γc-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes
M Kasprzycka, Q Zhang, A Witkiewicz, M Marzec, M Potoczek, X Liu, ...
The Journal of Immunology 181 (4), 2506-2512, 2008
572008
Apoptosis of T cells in the first trimester human decidua
M JERZAK, M Kasprzycka, P WIERBICKI, J Kotarski, A GÓRSKI
American Journal of Reproductive Immunology 40 (3), 130-135, 1998
501998
IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes
M Marzec, X Liu, M Kasprzycka, A Witkiewicz, PN Raghunath, M El-Salem, ...
Blood, The Journal of the American Society of Hematology 111 (4), 2181-2189, 2008
482008
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
J Pollheimer, J Bodin, O Sundnes, RJ Edelmann, SS Skånland, ...
Arteriosclerosis, thrombosis, and vascular biology 33 (2), e47-e55, 2013
432013
Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes
M Kasprzycka, M Majewski, ZJ Wang, A Ptasznik, M Wysocka, Q Zhang, ...
The American journal of pathology 168 (5), 1631-1641, 2006
432006
Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches
MA Wasik, Q Zhang, M Marzec, M Kasprzycka, HY Wang, X Liu
Seminars in oncology 36, S27-S35, 2009
332009
PU. 1 activates transcription of SHP-1 gene in hematopoietic cells
P Wlodarski, Q Zhang, X Liu, M Kasprzycka, M Marzec, MA Wasik
Journal of Biological Chemistry 282 (9), 6316-6323, 2007
322007
Cyclolinopeptide: a novel immunosuppressive agent with potential anti-lipemic activity
A Górski, M Kasprzycka, M Nowaczyk, Z Wieczoreck, IZ Siemion
Transplantation proceedings 33 (1-2), 2001
292001
Tenascins in fibrotic disorders—from bench to bedside
M Kasprzycka, C Hammarström, G Haraldsen
Cell Adhesion & Migration 9 (1-2), 83-89, 2015
282015
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome
JS Yoon, SM Newton, M Wysocka, AB Troxel, SD Hess, SK Richardson, ...
Journal of investigative dermatology 128 (2), 473-480, 2008
232008
Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies
J Hol, K Otterdal, UM Breland, E Stang, TM Pedersen, K Hagelsteen, ...
PLoS One 7 (7), e40673, 2012
222012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20